In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.

about

High guanine and cytosine content increases mRNA levels in mammalian cells Distinct host cell fates for human malignant melanoma targeted by oncolytic rodent parvoviruses.Novel adenovirus-based helper system to support production of recombinant parvovirus.

P2860

Q33243412-6968D888-AB8E-402A-BE68-809BABA0C9F5 Q37263031-79853BBA-D1D9-424E-ACFA-3FE08F836985 Q39814060-92D3E0CC-282F-4B82-9048-3DCE9D878BB6

P2860

In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.

Item

http://www.wikidata.org/entity/Q40498288

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

In vivo anti-tumour activity o ...... the human interleukin-2 cDNA.

@en

type

Item

label

In vivo anti-tumour activity o ...... the human interleukin-2 cDNA.

@en

prefLabel

In vivo anti-tumour activity o ...... the human interleukin-2 cDNA.

@en

P1476

In vivo anti-tumour activity o ...... g the human interleukin-2 cDNA

@en

P2093

Annick Brandenburger

http://www.w3.org/2001/XMLSchema#string

Charlotte Servais

http://www.w3.org/2001/XMLSchema#string

Jean-Denis Franssen

http://www.w3.org/2001/XMLSchema#string

Nathalie Clément

http://www.w3.org/2001/XMLSchema#string

Siew Chiat Cheong

http://www.w3.org/2001/XMLSchema#string

Thierry Velu

http://www.w3.org/2001/XMLSchema#string

P2860

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

Immunological gene therapy with ex vivo gene-modified tumor cells: a critique and a reappraisal.

Speculations on the role of ultraviolet radiation in the development of malignant melanoma.

Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression.

Interleukin-2 and interleukin-15: immunotherapy for cancer.

Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy.

Vectors based on autonomous parvoviruses: novel tools to treat cancer?

Autonomous parvovirus vectors: preventing the generation of wild-type or replication-competent virus.

Antineoplastic activity of parvoviruses.

Lymphokine gene therapy for cancer.

P304

189-197

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JGM.653

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Karim El Bakkouri

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15515141

http://www.w3.org/2001/XMLSchema#string

In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.

about

P2860

P2860

In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698